Clinical Trial

Ovarian Cancer Hemoscope Trial

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 16, 2025 (before its estimated June 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a prospective, gold standard observational trial designed to enroll consecutive, consenting ovarian cancer patients for the purpose of determining sensitivity of an assay that detects circulating tumor DNA. This observational pilot trial will also be used to examine the genetic variants/mutations present in the tumor tissue DNA.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2016-06-22; most recent amendment 2025-01-15.
Status change: Enrolling by Invitation → Active, Not Recruiting 2019-04-02
Trial Details
NCT Number NCT02811224
Lead Sponsor Scripps Translational Science Institute
Conditions Ovarian Neoplasms
Enrollment 50 participants
Start Date 2016-05
Primary Completion 2025-06 (estimated)
Study Completion 2030-07 (estimated)
Updated on ClinicalTrials.gov 2025-01-16